Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, up to 36 Months in Patients with Active Psoriatic Arthritis: Data from the Second Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
作者
Peter Nash,Laura C. Coates,Alan Kivitz,Philip J. Mease,Dafna D. Gladman,Jose A Covarrubias-Cobos,Dona Fleishaker,Cunshan Wang,Elizabeth M. Kudlacz,Sujatha Menon,Thijs Hendrikx,Keith S. Kanik
出处
期刊：The University of Queensland - Queensland's institutional digital repository [The University of Queensland] 日期：2017-01-01卷期号：69被引量：2
PDF的下载单位、IP信息已删除
(2025-6-4)
DW
cdercder
无极微光
Nole
Kao
GingerF
学术文献互助
秋风
rrr
wqh
v0id
一百分
我能私信骂你吗
翟思宇
掐钰
柚子茶
Criminology34
xjiao
挖掘机
dew
皖公网安备34019202002308
